(Q43509492)

24 November 2017

Estradiol levels in psychotic disorders (English)

1 reference

24 November 2017

1 reference

Huber TJ

1

1 reference

24 November 2017

Rollnik J

2

1 reference

24 November 2017

Wilhelms J

3

1 reference

24 November 2017

von zur Mühlen A

4

1 reference

24 November 2017

Emrich HM

5

1 reference

24 November 2017

Schneider U

6

1 reference

24 November 2017

1 January 2001

1 reference

24 November 2017

Psychoneuroendocrinology

1 reference

24 November 2017

26

1 reference

24 November 2017

1

1 reference

24 November 2017

27-35

1 reference

The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

Can estradiol modulate schizophrenic symptomatology?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2800%2900034-2

7 January 2021

10.1016/S0306-4530(00)00034-2

Identifiers

DOI

1 reference

24 November 2017

1 reference